Transforming growth factor β (TGF-β)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (mhc) class II-specific, regulatory CD4+ T cell lines

Journal of Experimental Medicine

Volumn 185, Issue 10, 1997, Pages 1769-1775

  Bridoux, Frank ^a   Badou, Abdallah ^a   Saoudi, Abdelhadi ^a   Bernard, Isabelle ^a   Druet, Elvira ^a   Pasquier, Régine ^a   Druet, Philippe ^a   Pelletier, Lucette ^a,b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; HELPER CELL; IMMUNOREGULATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL LINE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKIN-2; MAJOR HISTOCOMPATIBILITY COMPLEX; MERCURY POISONING; RATS; RATS, INBRED BN; RATS, INBRED LEW; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; THYMECTOMY; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030953068     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.10.1769     Document Type: Article

References (45)

1. H2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol. Today. 12: 223-227.
2. high T cells in mercury-induced autoimmunity in the Brown Norway rat. J. Exp. Med. 177:1309-1316.
3. Gillespie, K.M., F.J. Qasim, L.M. Tibbats, S. Thiru, D.B.G. Oliveira, and P.W. Mathieson. 1995. Interleukin-4 gene expression in mercury-induced autoimmunity. Scand. J. Immunol. 41:268-272.
4. Biancone, L., G. Andres, H. Ahn, A. Lim, C. Dai, R. Noelle, H. Yagita, C. De Martino, and I. Stamenkovic. 1996. Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type 2-mediated autoimmune disease. J. Exp. Med. 183:1473-1482.
5. Fillastre, J.P., P. Druet, and J.P. Mery. 1988. Proteinuric nephropathies associated with drugs and substances of abuse. In The Nephrotic Syndrome. J.S. Cameron and R.J. Glassock, editors. Marcel Dekker, New York. 697-744.
6. Rossert, J., L. Pelletier, R. Pasquier, and P. Druet. 1988. Autoreactive T cells in mercury-induced autoimmunity. Demonstration by limiting dilution analysis. Eur. J. Immunol. 18: 1761-1766.
7. Saoudi, A., M. Castedo, D. Nochy, C. Mandet, R. Pasquier, P. Druet, and L. Pelletier. 1995. Self reactive anti-class II Th2 cell lines derived from gold salt-injected rats trigger B cell polyclonal activation and transfer autoimmunity in CD8-depleted normal syngeneic recipients. Eur. J. Immunol. 25: 1972-1979.
8. + antiergotypic cells in Lewis rats. J. Exp. Med. 177:881-889.
9. Hunig, T., H.-J. Wallny, J.K. Hartley, A. Lawetzky, and G. Tiefenthaler. 1989. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J. Exp. Med. 169:73-86.
10. Williams, A.F., G. Galfré, and C. Milstein. 1977. Analysis of cell surface by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell. 12:663-673.
11. Brideau, R.J., P.B. Carter, W.R. Mc Master, D.W. Mason, and A.F. Williams. 1980. Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur. J. Immunol. 10: 609-615.
12. + T cells in vitro. J. Immunol. 156:2406-2412.
13. Dasch, J.R., D.R. Pace, W. Waegell, D. Inenaga, and L. Ellingsworth. 1989. Monoclonal antibodies recognizing transforming growth factor-β. Bioactivity neutralization and transforming growth factor β2 affinity purification. J. Immunol. 142:1536-1541.
14. Lucas, C., L.N. Bald, B.M. Fendly, M. Mora-Worms, I.S. Figari, E.J. Patzer, and M.A. Palladino. 1990. The autocrine production of transforming growth factor-β1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J. Immunol. 145:1415-1422.
15. van der Meide, P.H., A.H. Borman, H.G. Beljaars, M.A. Dubbeld, C.A.D. Botman, and H. Schellekens. 1989. Isolation and characterization of monoclonal antibodies directed to rat interferon-gamma. Lymphokine Res. 8:439-449.
16. + T cells in mercury-induced autoimmunity or immunosuppression in the rat. Scand. J. Immunol. 31:65-74.
17. Pelletier, L., R. Pasquier, J. Rossert, M.-C. Vial, C. Mandet, and P. Druet. 1988. Autoreactive T cells in mercury-induced autoimmunity. Ability to induce the autoimmune disease. J. Immunol. 140:750-754.
18. 2-induced autoimmunity in rats. Scand. J. Immunol. 37:406-412.
19. Sedgwick, J.D. 1988. Long-term depletion of CD8+ T cells in vivo in the rat: no observed role for CD8+ (cytotoxic/ suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 18:495-502.
20. Prigent, P., A. Saoudi, C. Pannetier, P. Graber, Y. Bonnefoy, P. Druet, and F. Hirsch. 1995. Mercuric chloride, a chemical responsible for Th2-mediated autoimmunity in Brown-Norway rats, directly triggers T cells to produce IL-4. J. Clin. Invest. 96:1484-1489.
21. Zauderer, M. 1989. Origin and significance of autoreactive T cells. Adv. Immunol. 45:417-437.
22. Nagata, M., and J.-W. Yoon. 1994. Prevention of autoimmune type I diabetes in biobreeding (BB) rats by a newly established, autoreactive T cell line from acutely diabetic BB rats. J. Immunol. 153:3775-3783.
23. Reich, E.-P., D. Scaringe, J. Yagi, S. Sherwin, and C.A. Janeway. 1989. Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes. 38:1647-1651.
24. Fillon, J., R. Baccala, J. Kuhn, P. Druet, and B. Bellon. 1997. Evidence for heterogeneous TCRVβ expression in mercury-induced autoimmune disorders in rats. Int. Immunol. 9:263-271.
25. Agrawal, B., M. Manickasundari, E. Fraga, and B. Singh. 1991. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice. J. Immunol. 147: 383-390.
26. Saoudi, A., B. Seddon, V. Heath, D. Fowell, and D. Mason. 1996. The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol. Rev. 149: 196-216.
27. Chen, Y., V.K. Kuchroo, J.-I. Inobe, D.A. Hafler, and H.L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (Wash. DC). 265:1237-1240.
28. Santos, L.M.B., A. Al-Sabbagh, A. Londono, and H. Weiner. 1994. Oral tolerance to myelin basic protein induces regulatory TGF-β secreting T cells in Peyer's patches of SJL mice. Cell. Immunol. 157:439-447.
29. + cells mediate active suppression. J. Immunol. 155:910-916.
30. Wahl, S.M. 1994. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180:1587-1590.
31. Kuruvilla, A.P., R. Shah, G.M. Hochwald, H.D. Liggitt, M.A. Palladino, and G.J. Thorbecke. 1991. Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA. 88:2918-2921.
32. Santambrogio, L., G.M. Hochwald, B. Saxena, C.-H. Leu, J.E. Martz, J.A. Carlino, N.H. Ruddle, M.A. Palladino, L.I. Gold, and J. Thorbecke. 1993. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J. Immunol. 151:1116-1127.
33. Jung, S., H.J. Schluesener, B. Schmidt, A. Fontana, K.V. Toyka, and H.-P. Hartung. 1994. Therapeutic effect of transforming growth factor-β2 on actively induced EAN but not adoptive transfer EAN. Immunology. 83:545-551.
34. Wahl, S.M., J.B. Allen, G.L. Costa, H.L. Wong, and J.R. Dasch. 1993. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor β. J. Exp. Med. 177:225-230.
35. Meyers, C.M., and C.J. Kelly. 1994. Immunoregulation and TGF-β1. Suppression of a nephritogenic murine T cell clone. Kidney Int. 46:1295-1301.
36. Neurath, M.F., I. Fuss, B.L. Kelsall, D.H. Presky, W. Waegell, and S. Strober. 1996. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 183:2605-2616.
37. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature (Lond.). 359:693-699.
38. Christ, M., N.L. McCartney-Francis, A.B. Kulkarni, J.M. Ward, D.E. Mizel, C.L. Mackall, R.E. Gress, K.L. Hines, H. Tian, S. Karlsson et al. 1994. Immune dysregulation in TGF-β1-deficient mice. J. Immunol. 153:1936-1946.
39. Dang, H., A.G. Geiser, J.J. Letterio, T. Nakabayashi, L. Kong, G. Fernandes, and N. Talal. 1995. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-β knockout mice. J. Immunol. 155:3205-3212.
40. low subset. J. Exp. Med. 172:1701-1708.
41. hi CD4+ T cells. Immunity. 1:553-582.
42. + T cells. J. Exp. Med. 183:2669-2674.
43. Modigliani, Y., A. Bandeira, and A. Coutinho. 1996. A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens. Immunol. Rev. 149: 156-174.
44. Lohse, A., and I.R. Cohen. 1992. Immunoregulation: studies of physiological and therapeutic autoreactivity by T cell vaccination. Springer Semin. Immunopathol. 14:179-186.
45. Cobbold, S.P., E. Adams, S.E. Marshall, J.D. Davies, and H. Waldmann. 1996. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol. Rev. 149:5-33.